<H1>Chapter DOI: 10.1208/aapsj070368<br/>Cited-By Count: 6</H1><table border="1" width="30%"><tr><td>Total References</td><td>31</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>26</td></tr><tr><td>BibStructured Count</td><td width="10%">31</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>22</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>5</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>5</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>3</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Lindstrom J. Nicotinic acetylcholine receptors in health and disease.<Emphasis Type="Italic">Mol Neurobiol</Emphasis>. 1997;15:193&#8211;222.</td><td><a href=http://dx.doi.org/10.1007/BF02740634>10.1007/BF02740634</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Dani JA, Biasi M, Liang Y, et al. Potential applications of nicotinic ligands in the laboratory and clinic.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2004;14:1837&#8211;1839.</td><td><a href=http://dx.doi.org/10.1016/j.bmcl.2003.07.036>10.1016/j.bmcl.2003.07.036</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Lloyd GK, Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2000;292:461&#8211;467.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Hogg RC, Bertrand D. Nicotinic acetylcholine receptors as drug targets.<Emphasis Type="Italic">Curr Drug Target CNS Neurol Disord</Emphasis>. 2004;3:123&#8211;130.</td><td><a href=http://dx.doi.org/10.2174/1568007043482507>10.2174/1568007043482507</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Curr Opin Ther Patents</Emphasis>. 2000;10:1561&#8211;1581.</td><td><a href=http://dx.doi.org/10.1517/13543776.10.10.1561>10.1517/13543776.10.10.1561</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:395&#8211;402.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Nicolotti O, Pellegrini-Calace M, Carrieri A, et al. Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2001;15:859&#8211;872.</td><td><a href=http://dx.doi.org/10.1023/A:1013115717587>10.1023/A:1013115717587</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Nielsen SF, Nielsen EO, Olsen GM, Liljefors T, Peters D. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2000; 43:2217&#8211;2226.</td><td><a href=http://dx.doi.org/10.1021/jm990973d>10.1021/jm990973d</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Dukat M, Fiedler W, Dumas D, et al. Pyrrolidine-modified and 6-substituted analogs of nicotine: a structure-affinity investigation.<Emphasis Type="Italic">Eur J Med Chem</Emphasis>. 1996;31:875&#8211;888.</td><td><a href=http://dx.doi.org/10.1016/S0223-5234(97)89850-9>10.1016/S0223-5234(97)89850-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Barlow RB, McLeod LJ. Some studies on cytisine and its methylated derivatives.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1969;35:161&#8211;174.</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1969.tb07977.x>10.1111/j.1476-5381.1969.tb07977.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, Author_FamilyName_2, Author_FamilyName_1, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Barlow RB, Johnson O. Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1989;98:799&#8211;808.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1989.tb14608.x>10.1111/j.1476-5381.1989.tb14608.x</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, Author_FamilyName_2, Year, VolumeID</td><td>CrossRef</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Tonder JE, Olesen PH, Hansen JB, Begtrup M, Pettersson I. An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labeled by [<Superscript>3</Superscript>H]-N-methylcarbamylcholine.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2001;15:247&#8211;258.</td><td><a href=http://dx.doi.org/10.1023/A:1008140021426>10.1023/A:1008140021426</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Tonder JE, Olesen PH. Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modeling.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2001;8:651&#8211;674.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Schmitt JD. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2000;7:749&#8211;800.</td><td><a href=http://dx.doi.org/10.2174/0929867003374660>10.2174/0929867003374660</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Sheridan RP, Nilakantan R, Dixon JS, Venkataraghavan R. The ensemble approach to distance geometry: application to the nicotinic pharmacophore.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1986;29:899&#8211;906.</td><td><a href=http://dx.doi.org/10.1021/jm00156a005>10.1021/jm00156a005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Glennon RA, Dukat M, Liao L. Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.<Emphasis Type="Italic">Curr Top Med Chem</Emphasis>. 2004;4:631&#8211;644.</td><td><a href=http://dx.doi.org/10.2174/1568026043451122>10.2174/1568026043451122</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Brejc K, van Dijk WJ, Klaassen R, et al. Crystal structure of AChBP reveals the ligand-binding domain of nicotinic receptors.<Emphasis Type="Italic">Nature</Emphasis>. 2001;411:269&#8211;276.</td><td><a href=http://dx.doi.org/10.1038/35077011>10.1038/35077011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibBook</td><td>Zupan J, Gasteiger J.<Emphasis Type="Italic">Neuronal Networks for Chemists</Emphasis>. New York, NY: VCH; 1993.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibBook</td><td>Kohonen T.<Emphasis Type="Italic">Self-organizing Maps</Emphasis>, Berlin, Germany: Springer, 2001.</td><td><a href=http://dx.doi.org/10.1007/978-3-642-56927-2>10.1007/978-3-642-56927-2</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>BookTitle, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Rogers D, Hopfinger AJ. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships.<Emphasis Type="Italic">J Chem Inf Comput Sci</Emphasis> 1994;34:854&#8211;866.</td><td><a href=http://dx.doi.org/10.1021/ci00020a020>10.1021/ci00020a020</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>von Korff M, Steger M. GPCR-tailored pharmacophore pattern recognition of small molecular ligands.<Emphasis Type="Italic">J Chem Info &amp; Comp Sci</Emphasis>. 2004;44:1137&#8211;1147.</td><td><a href=http://dx.doi.org/10.1021/ci0303013>10.1021/ci0303013</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Schneider G, Nettekoven M. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.<Emphasis Type="Italic">J Comb Chem</Emphasis>. 2003;5:233&#8211;237.</td><td><a href=http://dx.doi.org/10.1021/cc020092j>10.1021/cc020092j</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>So S, van Helden S, van Geerestein V, Karplus M. Quantitative structure-activity relationship studies of progesterone receptor binding steroids.<Emphasis Type="Italic">J Chem Info &amp; Comp Sci</Emphasis>. 2000;40:762&#8211;772.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1021/ci990130v>10.1021/ci990130v</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, FirstPage, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Yuan H, Parrill A. QSAR studies of HIV-1 integrase inhibition.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2002;10:4169&#8211;4183.</td><td><a href=http://dx.doi.org/10.1016/S0968-0896(02)00332-2>10.1016/S0968-0896(02)00332-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Gokhale V, Kulkarni V. Understanding the antifungal activity of terbinafine analogues using structure-activity relationship (QSAR) models.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2000;8:2487&#8211;2499.</td><td><a href=http://dx.doi.org/10.1016/S0968-0896(00)00178-4>10.1016/S0968-0896(00)00178-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Wilkins LHJr, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:400&#8211;410.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.043349>10.1124/jpet.102.043349</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Xu R, Dwoskin LP, Grinevich VP, Deaciuc G, Crooks PA. Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2001;11:1245&#8211;1248.</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(01)00193-7>10.1016/S0960-894X(01)00193-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA.<Emphasis Type="Italic">bis</Emphasis>-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> subtypes of neuronal nicotinic receptors.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2002;12:3067&#8211;3071.</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(02)00687-X>10.1016/S0960-894X(02)00687-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Grinevich VP, Crooks PA, Sumithran P, Haubner AJ, Ayers JT, Dwoskin LP. N-n-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H]dopamine overflow from superfused rat striatal.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:1011&#8211;1020.</td><td><a href=http://dx.doi.org/10.1124/jpet.103.051789>10.1124/jpet.103.051789</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Bayram E, Santago P, Harris R, Xiao Y-D, Clauset AJ, Schmitt JD. Genetic algorithms and self-organizing maps: a powerful combination for modeling complex QSAR and QSPR problems.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2004;187&#8211;9:483&#8211;493.</td><td><a href=http://dx.doi.org/10.1007/s10822-004-5321-2>10.1007/s10822-004-5321-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Crooks PA, Ravard A, Wilkins LH, Teng L, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [3H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 1995;36:91&#8211;102.</td><td><a href=http://dx.doi.org/10.1002/ddr.430360204>10.1002/ddr.430360204</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>